Financhill
Sell
6

CDT Quote, Financials, Valuation and Earnings

Last price:
$3.75
Seasonality move :
-30.43%
Day range:
$3.58 - $4.05
52-week range:
$3.25 - $4,710.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.10x
Volume:
84.7K
Avg. volume:
81.5K
1-year change:
-99.92%
Market cap:
$2.9M
Revenue:
--
EPS (TTM):
-$237.75

Earnings Data

Next earnings date for CDT
Aug 12
2025
Most recent earnings per share
-$19.80
Missed by $19.80
(May 15/2025)
Consensus Estimate
--
(May 15/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CDT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/15/2025 Q1 -- -- -$19.80 -- --
12/31/2024 Q4 -- -- -$7.95 -- --
11/14/2024 Q3 -- -- -$105.00 -- --
08/12/2024 Q2 -- -- -$105.00 -- --
05/14/2024 Q1 -- -- -$72.15 -- --
12/31/2023 Q4 -- -- -$43.80 -- --
11/20/2023 Q3 -- -- $15.00 -- --
06/30/2023 Q2 -- -- -$35.90 -- --
03/31/2023 Q1 -- -- -$34.63 -- --
12/31/2022 Q4 -- -- -$63.61 -- --
09/30/2022 Q3 -- -- -$19.80 -- --
03/31/2022 Q1 -- -- -$6.36 -- --

Conduit Pharmaceuticals Earnings Questions

  • How Much did Conduit Pharmaceuticals Generate in Revenue Last Quarter?

    Conduit Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Conduit Pharmaceuticals Beat Earnings Last Quarter?

    Conduit Pharmaceuticals announced earnings per share of -$19.80 which represents a miss of analyst forecast a -- per share.

  • Is Conduit Pharmaceuticals Profitable?

    Conduit Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Conduit Pharmaceuticals EPS Next Year?

    Conduit Pharmaceuticals's earnings are forecast to grow from -$307.95 per share to -- per share next year representing an increase of --.

  • When is Conduit Pharmaceuticals's Earnings Date?

    Conduit Pharmaceuticals's next earnings date is August 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
58
TNXP alert for May 28

Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.

Buy
70
AGFY alert for May 29

Agrify [AGFY] is up 18.95% over the past day.

Buy
88
SMR alert for May 28

NuScale Power [SMR] is down 0.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock